It is noteworthy that the DATS treatment of xenografted mice reduced both the tumor volume and weight compared to the control mice, also potentiating the anticancer efficacy of cisplatin by suppressing the NRF2/AKT pathways [130]. Here, NFE2L2 is linked to neoplasm.